140 related articles for article (PubMed ID: 27060861)
1. Risk assessment of drug-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a disproportionality analysis using the French Pharmacovigilance Database.
Agier MS; Boivin N; Maruani A; Giraudeau B; Gouraud A; Haramburu F; Jean Pastor MJ; Machet L; Jonville-Bera AP
Br J Dermatol; 2016 Nov; 175(5):1067-1069. PubMed ID: 27060861
[No Abstract] [Full Text] [Related]
2. Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect?
Daveluy A; Milpied B; Barbaud A; Lebrun-Vignes B; Gouraud A; Laroche ML; Ciobanu E; Bégaud B; Moore N; Miremont-Salamé G; Haramburu F;
Eur J Clin Pharmacol; 2012 Jan; 68(1):101-5. PubMed ID: 21792562
[TBL] [Abstract][Full Text] [Related]
3. Bleedings induced by oral anticoagulants: a study of adverse drug reactions reported to Midi-Pyrénées PharmacoVigilance Centre between 2003 and 2006.
Boudal P; Sommet A; Bagheri H; Pathak A; Montastruc JL
Therapie; 2010; 65(6):567-9. PubMed ID: 21176763
[No Abstract] [Full Text] [Related]
4. Spanish Guidelines for Diagnosis, Management, Treatment, and Prevention of DRESS Syndrome.
Cabañas R; Ramírez E; Sendagorta E; Alamar R; Barranco R; Blanca-López N; Doña I; Fernández J; Garcia-Nunez I; García-Samaniego J; Lopez-Rico R; Marín-Serrano E; Mérida C; Moya M; Ortega-Rodríguez NR; Rivas Becerra B; Rojas-Perez-Ezquerra P; Sánchez-González MJ; Vega-Cabrera C; Vila-Albelda C; Bellón T
J Investig Allergol Clin Immunol; 2020; 30(4):229-253. PubMed ID: 31932268
[TBL] [Abstract][Full Text] [Related]
5. Antituberculosis Drug-Associated DRESS: A Case Series.
Allouchery M; Logerot S; Cottin J; Pralong P; Villier C; Ben Saïd B;
J Allergy Clin Immunol Pract; 2018; 6(4):1373-1380. PubMed ID: 29274824
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.
Hiransuthikul A; Rattananupong T; Klaewsongkram J; Rerknimitr P; Pongprutthipan M; Ruxrungtham K
Allergol Int; 2016 Oct; 65(4):432-438. PubMed ID: 27134114
[TBL] [Abstract][Full Text] [Related]
7. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases.
Chen YC; Chiu HC; Chu CY
Arch Dermatol; 2010 Dec; 146(12):1373-9. PubMed ID: 20713773
[TBL] [Abstract][Full Text] [Related]
8. Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.
Fernando SL
Australas J Dermatol; 2014 Feb; 55(1):15-23. PubMed ID: 23866082
[TBL] [Abstract][Full Text] [Related]
9. Allergic delayed drug hypersensitivity is more frequently diagnosed in drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome than in exanthema induced by beta-lactam antibiotics.
Ben-Said B; Arnaud-Butel S; Rozières A; Rodet K; Bérard F; Nicolas JF; Nosbaum A
J Dermatol Sci; 2015 Oct; 80(1):71-4. PubMed ID: 26341696
[No Abstract] [Full Text] [Related]
10. Identification of novel signal of clobazam-associated drug reaction with eosinophilia and systemic symptoms syndrome: A disproportionality analysis.
Sharma A; Kumar A
Acta Neurol Scand; 2022 Nov; 146(5):623-627. PubMed ID: 36029138
[TBL] [Abstract][Full Text] [Related]
11. Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: A retrospective study.
Soria A; Bernier C; Veyrac G; Barbaud A; Puymirat E; Milpied B
J Am Acad Dermatol; 2020 Mar; 82(3):606-611. PubMed ID: 31562941
[TBL] [Abstract][Full Text] [Related]
12. Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients.
Avancini J; Maragno L; Santi CG; Criado PR
Clin Exp Dermatol; 2015 Dec; 40(8):851-9. PubMed ID: 26271788
[TBL] [Abstract][Full Text] [Related]
13. Drug reaction with eosinophilia and systemic symptoms in pediatric patients: A clinicopathological study of 16 cases in the National Center of Pharmacovigilance of Tunisia.
Kaabi W; Zaiem A; Aouinti I; Charfi O; Kastalli S; El Aidli S; Daghfous R; Lakhoua G
Therapie; 2019 Oct; 74(5):531-535. PubMed ID: 31023620
[TBL] [Abstract][Full Text] [Related]
14. Eosinophilic drug reactions detected by a prospective pharmacovigilance programme in a tertiary hospital.
Ramírez E; Medrano-Casique N; Tong HY; Bellón T; Cabañas R; Fiandor A; González-Ramos J; Herranz P; Trigo E; Muñoz M; Borobia AM; Carcas AJ; Frías J
Br J Clin Pharmacol; 2017 Feb; 83(2):400-415. PubMed ID: 27543764
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of DRESS syndrome.
López-Rocha E; Blancas L; Rodríguez-Mireles K; Gaspar-López A; O'Farrill-Romanillos P; Amaya-Mejía A; Galindo-Pacheco L; Campos-Romero F; Aguilar-Hinojosa N; Suárez G
Rev Alerg Mex; 2014; 61(1):14-23. PubMed ID: 24912998
[TBL] [Abstract][Full Text] [Related]
16. Drug Reaction with Eosinophilia and Systemic Symptoms or Virus Reactivation with Eosinophilia and Systemic Symptoms.
Descamps V; Brunet-Possenti F
Pediatr Dermatol; 2016 Sep; 33(5):562. PubMed ID: 27595878
[No Abstract] [Full Text] [Related]
17. Recurrence of drug-induced reactions in DRESS patients.
Picard D; Vellar M; Janela B; Roussel A; Joly P; Musette P
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):801-4. PubMed ID: 24628777
[TBL] [Abstract][Full Text] [Related]
18. [Hypersensitivity to fluindione (Previscan). Positive skin patch tests].
Frouin E; Roth B; Grange A; Grange F; Tortel MC; Guillaume JC
Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 1):1000-2. PubMed ID: 16446646
[TBL] [Abstract][Full Text] [Related]
19. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
Kano Y; Tohyama M; Aihara M; Matsukura S; Watanabe H; Sueki H; Iijima M; Morita E; Niihara H; Asada H; Kabashima K; Azukizawa H; Hashizume H; Nagao K; Takahashi H; Abe R; Sotozono C; Kurosawa M; Aoyama Y; Chu CY; Chung WH; Shiohara T
J Dermatol; 2015 Mar; 42(3):276-82. PubMed ID: 25623158
[TBL] [Abstract][Full Text] [Related]
20. [DRESS syndrome].
Khaled A; Souissi A; Zeglaoui F; El Fekih N; Daghfous R; Fazaa B
Tunis Med; 2012 Oct; 90(10):749-51. PubMed ID: 23096521
[No Abstract] [Full Text] [Related]
[Next] [New Search]
